27th World Congress of Asthma (WCA 2024)

27th World Congress of Asthma (WCA 2024) is organized by FREI S.A. and will be held from Oct 23 - 25, 2024 at Hotel NH Collection Genova Marina, Genoa, Liguria, Italy.

Topics:
Acute asthma:
• Causes and risk factors
• Management and prevention
• Asthma in the ICU

Allergic Rhinitis Impact on Asthma:
• Pathophysiology of Allergic Rhinitis and Asthma
• Impact of Allergic Rhinitis Therapies in Asthma
• Allergen Immunotherapy in Asthma

Allergy:
• Allergy testing
• Aero-allergens and airways
• The ARIA initiative

Asthma and COPD:
• Influence of Tobacco on asthma
• Is Asthma COPD overlap a distinct entity
• Management of ACO

Asthma and specific conditions and populations:
• Asthma and pregnancy
• Asthma in the elderly
• Managing Allergy & Asthma in Resource Poor Settings
• Asthma in the obese
• Occupational asthma

Asthma co-morbidities:
• Asthma and rhinitis
• Asthma and upper airways dysfunction
• Obesity and asthma
• Chronic Rhinosinusitis and T2 inflammation
• Asthma and nasal polyps

Asthma diagnosis:
• Under and overtreatment of asthma
• Standards for the diagnosis of asthma
• Pulmonary function tests

Asthma epidemiology:
• Incidence and prevalence of asthma in the world
• Morbidity and mortality from asthma
• Natural history of severe asthma: can it be altered

Asthma pathophysiology:
• Airway inflammation subtypes
• Biomarkers
• Airway remodeling

Asthma phenotypes:
• Asthma phenotyping
• Severe asthma
• Occupational asthma
• Exercise-induced asthma and asthma in the athlete
• Eosinophilic asthma
• Non-eosinophilic asthma
• T2 vs Non-T2 asthma
• Obesity and asthma

Asthma treatment:
• Care gaps
• Management of mild asthma
• New asthma guidelines
• New inhalers
• Future treatment of asthma
• Non-pharmacologic asthma therapies
• Non-biologic treatments for asthma
• Impact of new Asthma Biologicals on Asthma Outcomes
• Is there still a role of OCS in long-term treatment of severe asthma
• Is there still a role of SABAs in long-term treatment of severe asthma

Clinical aspects of asthma: the patient perspective:
• Perception of asthma symptoms
• Asthma education

Drugs for asthma and COPD:
• ?2-agonists
• Inhaled corticosteroids
• Anti-cholinergics
• Leukotriene antagonists
• Combination therapies (double and triple therapy)
• Monoclonal antibodies

Environmental factors and asthma:
• Allergens
• Workplace inhalants
• Air pollution
• Climate change

GINA update:
• New GINA report in adolescent and adults
• New GINA report in children
• GINA recommendations on severe asthma

Non-invasive airway inflammation assessment:
• The role of inflammometry in asthma
• Blood and Induced sputum analysis
• Exhaled NO measures

Precision medicine:
• Personalized medicine: how to make it happen
• Biomarkers of asthma
• Targeting asthma therapy
• IL5 versus IgE as a Therapeutics target in Asthma
• Anti-IgE
• Anti-IL5
• Anti-IL4-IL-13
• Other cytokines antagonists

COVID-19 and other respiratory infections and asthma:
• The COVID Pandemic and asthma
• Severe COVID pneumonia management
• Other Bacterial and Viral infections
• Vaccination

Risk factors of asthma:
• Vitamin deficiency and nutritional factors
• Smoking (direct and secondary)
• Exposure to bacteria (microbiome)
• Genetic factors

Severe asthma:
• Assessment of severe asthma
• Management of difficult-to-control asthma
• Severe pediatric asthma
• New monoclonal antibodies
• Can we predict response to therapies
• New therapies to come

Various topics on asthma:
• History of asthma and its treatment
• Conditions mimicking asthma
• RCTs or Real-life trials
• WHO-GARD, ARIA and ISAR initiatives
• Surveys of biologics use in asthma